Otezla XR 75 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FZ96B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,498
Award facts
- Contract value 100% obligated
- $13,497.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,497.56 to AmerisourceBergen Drug Corp for the supply of Otezla XR 75 mg tablets (30-count unit) on December 11, 2025, with completion expected by December 12, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA. The company supplies pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Otezla XR—a treatment for psoriasis and psoriatic arthritis—exemplifies the contractor's ongoing role as a critical vendor in the federal supply chain for military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FZ96B?
SPE2DR26FZ96B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FZ96B worth?
The government has obligated $13,498 on SPE2DR26FZ96B.
Is contract SPE2DR26FZ96B an order under another contract?
Yes. SPE2DR26FZ96B is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ96B competed?
The extent of competition for SPE2DR26FZ96B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award